Epigallocatechin Gallate and Other Antural Compounds in HPV Infections

• Status: Active, not recruiting
• Trial end date: 2024-07-15
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators enroll patients with a PAP-test cytology reporting LSIL or ASCUS.

Pateitns undergo HPV-DNA test for screening. Patients are treated with Epigallocatechin galalte, hyaluronic acid, folic acid and Vitamin B12 by oral route.

After three months of treatment PAP-test and HPV-DNA test will be repeated.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centro di Ricerca Clinica Salentino

Criteria

Inclusion Criteria:

• Positivity to HPV-DNA test

• PAP-test reporting LSIL or ASCUS

Exclusion Criteria:

• HPV-related pathologies or complicances apart from LSIL or ASCUS

• Diagnosis of cancer